[However, the economist added that he wasn't surprised that companies such as Novell and Palm would give input to the states.] That's inevitable, ... The mere involvement of a competitor is not a problem to me.

This is pretty much everything that the plaintiff had been looking for. This points to a strong remedy and not a slap on the wrist, though there are other strong remedies besides breakup.

We have a patent system that is out of balance and in some respects is impeding innovation and economic growth.

That's outside of the principals I explain in my direct testimony.

These anti-competitive settlements in the pharmaceutical industry are a major anti-trust problem. These settlements are thwarting competition and depriving consumers of the benefits of low-cost generic drugs.

The BlackBerry is the perfect example of what's wrong with our patent system, but it is certainly not the only one.